UHS (UHS) CFO Steve Filton exercises options, withholds shares for taxes

Rhea-AI Filing Summary

UNIVERSAL HEALTH SERVICES INC Executive Vice President & CFO Steve Filton reported a series of compensation-related equity transactions involving Class B Common Stock. On March 12, 2026, he exercised options to acquire 39,200 shares at $138.80 per share and 44,037 shares at $152.68 per share, fully converting these option awards into stock.

To cover exercise price and tax obligations, a total of 71,752 and 6,818 shares of Class B Common Stock were disposed of via tax-withholding transactions, not open-market sales. He also received 16,044 shares as a grant tied to performance-based RSUs that vested after the company met specified performance criteria. Following these transactions, Filton directly holds 139,212 Class B shares and has additional indirect holdings of 80,500 shares in each of two 2020 irrevocable trusts.

Insider Trade Summary

Net Buyer: 20,711 shares

Net Buy 9 txns

Insider FILTON STEVE

Role Executive Vice President & CFO

Type	Security	Shares	Price	Value
Exercise	Option To Purchase Class B Common Stock	39,200	$0.00	$0.00
Exercise	Option To Purchase Class B Common Stock	44,037	$0.00	$0.00
Exercise	Class B Common Stock	39,200	$138.80	$5.44M
Exercise	Class B Common Stock	44,037	$152.68	$6.72M
Exercise Price or Tax Liability	Class B Common Stock	71,752	$192.28	$13.80M
Grant/Award	Class B Common Stock	16,044	$0.00	$0.00
Exercise Price or Tax Liability	Class B Common Stock	6,818	$190.49	$1.30M
holding	Class B Common Stock	--	--	--
holding	Class B Common Stock	--	--	--

Holdings After Transaction: Option To Purchase Class B Common Stock — 0 shares (Direct); Class B Common Stock — 139,212 shares (Direct); Class B Common Stock — 80,500 shares (Indirect, The Betsy H. Filton 2020 Irrevocable Trust); Class B Common Stock — 80,500 shares (Indirect, The Steve G. Filton 2020 Irrevocable Trust)

Footnotes (2)

1. F1. Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.
2. F2. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

FAQ

What did UHS executive Steve Filton report in this Form 4 filing?

Steve Filton reported exercising stock options and related tax-withholding transactions, along with a performance-based RSU vesting. These actions converted option awards into Class B Common Stock and adjusted his holdings through non-market dispositions to satisfy exercise price and tax obligations.

How many Universal Health Services (UHS) shares did Steve Filton acquire through option exercises?

Filton exercised options to acquire 39,200 Class B shares at $138.80 and 44,037 shares at $152.68 per share. These exercises converted previously granted options into a total of 83,237 shares of Universal Health Services Class B Common Stock.

Were any of Steve Filton’s UHS share transactions open-market sales?

No open-market sales were reported. The Form 4 shows dispositions coded as “F,” meaning shares were withheld to pay the option exercise price or tax liabilities. These are mechanistic tax-withholding events rather than discretionary sales in the market.

What performance-based RSUs vested for UHS CFO Steve Filton?

The filing notes 16,044 shares issued upon vesting of performance-based RSUs awarded on March 15, 2023. These vested after Universal Health Services met specified performance criteria, and the shares were therefore newly issuable and became reportable at vesting.

What are Steve Filton’s reported UHS share holdings after these transactions?

After the reported transactions, Filton directly holds 139,212 shares of UHS Class B Common Stock. He also has indirect ownership of 80,500 shares in each of two 2020 irrevocable trusts, reflecting additional exposure through trust-held positions.

What do the tax-withholding transactions in the UHS Form 4 indicate?

The two “F”-coded transactions, totaling 71,752 and 6,818 shares, indicate shares delivered to cover option exercise cost or tax liabilities. Such dispositions are automatic for tax compliance and do not represent elective open-market selling decisions by the insider.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/13/2026 - 04:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FILTON STEVE

(Last) (First) (Middle)

UNIVERSAL HEALTH SERVICES, INC.

367 SOUTH GULPH ROAD

(Street)

KING OF PRUSSIA PA 19406

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	03/12/2026		M		39,200	A	$138.8	157,701	D
Class B Common Stock	03/12/2026		M		44,037	A	$152.68	201,738	D
Class B Common Stock	03/12/2026		F		71,752	D	$192.28	129,986	D
Class B Common Stock	03/12/2026		A(1)		16,044	A	$0	146,030	D
Class B Common Stock	03/12/2026		F		6,818	D	$190.49	139,212	D
Class B Common Stock								80,500	I	The Betsy H. Filton 2020 Irrevocable Trust
Class B Common Stock								80,500	I	The Steve G. Filton 2020 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option To Purchase Class B Common Stock	$138.8	03/12/2026		M			39,200	(2)	03/16/2026	Class B Common Stock	39,200	$0	0	D
Option To Purchase Class B Common Stock	$152.68	03/12/2026		M			44,037	(2)	03/16/2026	Class B Common Stock	44,037	$0	0	D

Explanation of Responses:

1. Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.

2. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

	/s/ Steve Filton	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.